The news: OpenAI debuted OpenAI for Healthcare aimed at medical professionals and healthcare organizations.

• The healthcare tools include ChatGPT for Healthcare and OpenAI API platform.
• ChatGPT for Healthcare is similar to basic ChatGPT, but offers a closed, secure workspace for clinicians, administrators, and researchers. Cedars-Sinai Medical Center, Memorial Sloan Kettering Cancer Center, and Stanford Medicine Children’s Health are among its first users.
• OpenAI API platform lets healthcare organizations embed its latest AI models, including GPT-5.2, directly into their systems with HIPAA compliance.
• The platform was developed with ongoing feedback from 260 physicians globally and drew answers from “millions” of peer-reviewed research studies, public health, and clinical guidelines, although OpenAI did not detail specific sources.
• The announcement follows on the heels of the launch of its consumer-focused ChatGPT Health.

Why it matters: OpenAI already leads when it comes to consumer AI use for healthcare questions and advice, but healthcare systems and providers are a new niche for ChatGPT.

• More than 40 million consumers use ChatGPT every day for health information and advice, per OpenAI data.
• Among physicians, 16% use ChatGPT, but that’s a distant second to 45% who use OpenEvidence, according to an Offcall survey of 1,000 physicians published in December. 5% use Abridge and 3% use Claude (3%).
• OpenEvidence, which brands itself as ChatGPT for doctors, relies on content partnerships and licensing deals with medical journals and peer-reviewed sources. It counts more than 350,000 doctors—about one-third of licensed US physicians—registered on its platform.

Implications for healthcare providers: Scale and reach can accelerate AI adoption in healthcare, but consumer and clinical markets operate by different rules. While accuracy is key for both, physicians and healthcare systems require validated, transparent, and evidence-backed tools to safely use AI in clinical practice.

OpenAI’s push into both consumer and professional healthcare underscores the size of the opportunity, but also highlights those challenges. Even though ChatGPT benefits from broad consumer adoption, it’s also playing catch-up with medical-specific platforms that are already embedded in physician workflows and built on licensed, peer-reviewed content.

This content is part of EMARKETER’s subscription Briefings, where we pair daily updates with data and analysis from forecasts and research reports. Our Briefings prepare you to start your day informed, to provide critical insights in an important meeting, and to understand the context of what’s happening in your industry. Not a subscriber? Click here to get a demo of our full platform and coverage.